BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12699750)

  • 1. Structure-activity relationships of novel anti-malarial agents. Part 6: N-(4-arylpropionylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides.
    Wiesner J; Fucik K; Kettler K; Sakowski J; Ortmann R; Jomaa H; Schlitzer M
    Bioorg Med Chem Lett; 2003 May; 13(9):1539-41. PubMed ID: 12699750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of novel anti-malarial agents. Part 3: N-(4-acylamino-3-benzoylphenyl)-4-propoxycinnamic acid amides.
    Wiesner J; Kettler K; Jomaa H; Schlitzer M
    Bioorg Med Chem Lett; 2002 Feb; 12(4):543-5. PubMed ID: 11844668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of novel anti-malarial agents: part 5. N-(4-acylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides.
    Wiesner J; Kettler K; Sakowski J; Ortmann R; Jomaa H; Schlitzer M
    Bioorg Med Chem Lett; 2003 Feb; 13(3):361-3. PubMed ID: 12565929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of novel anti-malarial agents. Part 7: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-furyl)acrylic acid amides with polar moieties.
    Wiesner J; Mitsch A; Jomaa H; Schlitzer M
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2159-61. PubMed ID: 12798326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-thiol farnesyltransferase inhibitors: N-(4-acylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides.
    Kettler K; Sakowski J; Silber K; Sattler I; Klebe G; Schlitzer M
    Bioorg Med Chem; 2003 Apr; 11(7):1521-30. PubMed ID: 12705292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone.
    Altenkämper M; Bechem B; Perruchon J; Heinrich S; Mädel A; Ortmann R; Dahse HM; Freunscht E; Wang Y; Rath J; Stich A; Hitzler M; Chiba P; Lanzer M; Schlitzer M
    Bioorg Med Chem; 2009 Nov; 17(22):7690-7. PubMed ID: 19819706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of novel anti-malarial agents part 8. Effect of different central aryls in biarylacryloylaminobenzophenones on antimalarial activity.
    Wiesner J; Mitsch A; Altenkämper M; Ortmann R; Jomaa H; Schlitzer M
    Pharmazie; 2003 Dec; 58(12):854-6. PubMed ID: 14703959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activity.
    Kettler K; Wiesner J; Silber K; Haebel P; Ortmann R; Sattler I; Dahse HM; Jomaa H; Klebe G; Schlitzer M
    Eur J Med Chem; 2005 Jan; 40(1):93-101. PubMed ID: 15642414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
    Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of novel anti-malarial agents: 1. arylacyl and cyclohexylacyl derivatives of 5-amino-2-tolylacetylaminobenzophenone.
    Wiesner J; Mitsch A; Wissner P; Jomaa H; Schlitzer M
    Pharmazie; 2001 Jun; 56(6):443-4. PubMed ID: 11446161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of novel anti-malarial agents. Part 4: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-furyl)acrylic acid amides.
    Wiesner J; Mitsch A; Wissner P; Krämer O; Jomaa H; Schlitzer M
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2681-3. PubMed ID: 12217353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-(Arylpropionylamino)- and 2-(arylacryloylamino)benzophenones: farnesyltransferase inhibition and antimalarial activity.
    Fucik K; Kettler K; Wiesner J; Ortmann R; Unterreitmeier D; Krauss J; Bracher F; Jomaa H; Schlitzer M
    Pharmazie; 2004 Oct; 59(10):744-52. PubMed ID: 15544051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(aminoacylamino)benzophenones: farnesyltransferase inhibition and antimalarial activity.
    Kettler K; Wiesner J; Fucik K; Sakowski J; Ortmann R; Dahse HM; Jomaa H; Schlitzer M
    Pharmazie; 2005 Sep; 60(9):677-82. PubMed ID: 16222868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Biological Evaluation of Peptidomimetic N-Substituted Cbz-4-Hyp-Hpa-Amides as Novel Inhibitors of Plasmodium falciparum.
    Bacherikov VA; Chittiboyina AG; Avery MA
    Chem Biodivers; 2017 Aug; 14(8):. PubMed ID: 28498611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Acylamino-5-chlorobenzophenones with enhanced selectivity towards malaria parasites.
    Heinrich S; Altenkämper M; Bechem B; Perruchon J; Ortmann R; Dahse HM; Wang Y; Lanzer M; Schlitzer M
    Eur J Med Chem; 2011 Apr; 46(4):1331-42. PubMed ID: 21345543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological characterisation and structure activity relationships of aromatic bisamidines active against Plasmodium falciparum.
    Sauer B; Skinner-Adams TS; Bouchut A; Chua MJ; Pierrot C; Erdmann F; Robaa D; Schmidt M; Khalife J; Andrews KT; Sippl W
    Eur J Med Chem; 2017 Feb; 127():22-40. PubMed ID: 28038325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-parasitic activity of achiral N-benzylated phosphoramidic acid derivatives.
    Adeyemi CM; Conibear AC; Mutorwa MK; Nokalipa IC; Isaacs M; Mnkandhla D; Hoppe HC; Lobb KA; Klein R; Kaye PT
    Bioorg Chem; 2020 Aug; 101():103947. PubMed ID: 32559578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of hybrid bis-cationic salts as antimalarial drugs.
    Ortial S; Denoyelle S; Wein S; Berger O; Durand T; Escale R; Pellet A; Vial H; Vo-Hoang Y
    ChemMedChem; 2010 Jan; 5(1):52-5. PubMed ID: 19943278
    [No Abstract]   [Full Text] [Related]  

  • 19. 3D-QSAR analysis of antimalarial farnesyltransferase inhibitors based on a 2,5-diaminobenzophenone scaffold.
    Xie A; Sivaprakasam P; Doerksen RJ
    Bioorg Med Chem; 2006 Nov; 14(21):7311-23. PubMed ID: 16837204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Arylthieno[2,3-
    Schweda SI; Alder A; Gilberger T; Kunick C
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32668631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.